Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 1553 of 6372
-
Custom immune attack: new gene therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase 1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study aims to unlock immune secrets of nasopharyngeal cancer
Knowledge-focused Not yet recruitingTo analyze the spatiotemporal dynamic evolution of nasopharyngeal carcinoma before and after immunotherapy and during tumor progression, 2\~3 key cell subsets or node molecules were screened to predict the curative effect. Spatial metabolome and organoids were used to elucidate t…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New cocktail of drugs and radiation targets Hard-to-Treat sarcoma
Disease control Not yet recruitingThis study intends to enroll patients with advanced soft tissue sarcoma, employing immunotherapy combined with eribulin, anlotinib, and radiotherapy as subsequent-line treatment to preliminarily explore its efficacy and safety. QL1706, a dual-targeting agent against PD-1 and CTLA…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New cocktail of drugs and radiation takes on Hard-to-Treat sarcoma
Disease control Not yet recruitingThis study employs a multicenter, single-arm trial design. Participants will receive a treatment regimen consisting of "anlotinib plus bempegaldesleukin concurrent with radiotherapy," followed by a maintenance therapy phase of "anlotinib plus bempegaldesleukin concurrent with che…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:22 UTC
-
Papaya leaf extract tested as dengue treatment for kids
Disease control By invitation onlyThe goal of this clinical trial is to evaluate whether Carica papaya leaf extract (CPLE) can improve platelet counts in children aged 2 to 12 years diagnosed with dengue fever and thrombocytopenia. The main questions it aims to answer are: Does Carica papaya leaf extract signifi…
Phase 2 • Sponsor: Ziauddin Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:24 UTC
-
New hope for breast cancer survivors: laser and gel may ease vaginal atrophy without hormones
Symptom relief Not yet recruitingThe genito-urinary syndrome of menopause severely affects patients with a history of gynecological cancer, especially those diagnosed with breast cancer. At the present time, we do not have solid scientific evidence on treatments that can be effective and safe to address this pat…
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Symptom relief
Last updated Jun 26, 2026 19:20 UTC
-
Can enzyme pills help pancreatitis patients regain lost weight?
Disease control Not yet recruitingIn this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, we propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). We will include patients of 18-60yrs age and both genders with \>50…
Phase 3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New antibody treatment could tame rare brain disease Flare-Ups
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of different monoclonal antibody in the acute phase of neuromyelitis optica spectrum disorder (MAAP-NMO). It will also examine immune-related biomarkers and their relationship with treatment response to provide evidence for opti…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
New combo procedure aims to seal aortic tears more completely
Disease control Not yet recruitingThis multicenter, prospective, observational study aims to evaluate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) combined with false lumen embolization using vascular plugs in patients with acute type B aortic dissection. Despite TEVAR being a standard t…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New electric pulse treatment aims to tame atrial fibrillation
Disease control Not yet recruitingThis study is a prospective, single-center, single-arm clinical trial planning to screen and enroll 200 subjects. It aims to evaluate the efficacy and safety of pulsed field ablation (PFA) using the FARAPULSE™ system for pulmonary vein isolation (PVI) and superior vena cava isola…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:15 UTC
-
Can a common supplement reverse stomach cancer risk?
Disease control Not yet recruitingThe goal of this clinical trial is to investigate the efficacy of Berberine in treating gastric intestinal metaplasia in Helicobacter pylori-negative adults. It will also learn about the safety of Berberine. The main questions it aims to answer are: Does Berberine promote the re…
Phase 4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
Can a 'Baby Dose' of hormone drugs prevent breast cancer with fewer side effects?
Prevention Recruiting nowThe purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.
Phase 2 • Sponsor: Andrea DeCensi • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
New Artery-Clearing procedure could save legs from amputation
Disease control OngoingPeripheral artery disease (PAD) affects \>200 millionadults worldwide and is amajor cause of morbidity ranging from exertional lower extremity pain to ischemic rest pain and ulcer formation. Endovascular treatment options for PAD have increased dramatically in the past several d…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Virus therapy takes on tough melanoma in early trial
Disease control Recruiting nowThis is Phase I, open label, multi-center clinical trial evaluating an investigational treatment, Adze1.C. Adze1.C is a type of oncolytic virus therapy for adults with advanced Melanoma that have not responded to standard treatments. Oncolytic viruses are designed to infect and d…
Phase 1 • Sponsor: Adze Biotechnology Australia Pty Ltd • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Dancing away danger: Music-Based exercise may cut falls in seniors with diabetes
Disease control Recruiting nowThe DIACTIVE study is a randomized controlled trial with a 5- year follow-up designed to evaluate the impact of comprehensive screening and multicomponent interventions on fall prevention, bone health, nerve function and cardiovascular outcomes in people with diabetes aged 65 yea…
Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New MRI-Guided radiation aims to tame tough prostate cancer
Disease control By invitation onlyThe implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program will allow to reproduce the results obtained with state-of-the-art brachytherapy combined with EBRT with the added advantage of convenience.
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Fish oil cocktail takes on stubborn ear fluid in adults
Disease control CompletedBrief Summary - OMENUTS Trial Otitis media with effusion (OME) is a condition in which fluid accumulates in the middle ear, causing conductive hearing loss, ear fullness, tinnitus, and Eustachian tube dysfunction. Although OME is well-recognized in children, it also affects adult…
Phase 4 • Sponsor: Isola Tiberina - Gemelli Isola Hospital, Rome, Italy • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can robot legs help Non-Walking kids join in at school?
Symptom relief By invitation onlyRobot-assisted walking offers children who are unable to walk new avenues for participation in their communities in addition to health benefits. Disappointingly, most children cannot access this impactful technology. One of every 1000 children cannot walk due to cerebral palsy,1 …
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can we predict growth problems in childhood cancer survivors?
Knowledge-focused OngoingThe Growth study investigates nutritional status, BMI, and linear growth trajectories from birth to adulthood in childhood cancer patients and survivors. Specifically, it aims to identify the predictors driving these distinct growth and weight trajectories and evaluate the consis…
Sponsor: Fabiën Belle • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could a Finger-Prick test replace blood draws for kidney patients?
Diagnosis CompletedThis study evaluates the clinical performance of a non-invasive digital diagnostic test (KF4+, developed and manufactured by Gisens Biotech) for the measurement of urea and potassium in capillary blood in patients with end-stage renal disease (ESRD) undergoing dialysis. Measureme…
Sponsor: Gisens Biotech • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC